Celsense
Innovative biotechnology solutions enabling precise monitoring of transplanted cells for advancements in regenerative medicine and immunotherapy.
Innovative biotechnology solutions enabling precise monitoring of transplanted cells for advancements in regenerative medicine and immunotherapy.
Celsense is an innovative biotechnology company that provides unique MRI agents enabling scientists and clinicians to track the location and quantity of transplanted cells. Founded in 2005, the company operates within the Biotechnology and Health Care industries, catering to the critical areas of regenerative medicine, immunotherapy, and the analysis of inflammation and immune system responses. Celsense is actively engaged with top pharmaceutical and biotechnology organizations and has secured a $353.00K Debt Financing investment on 06 July 2016. This strategic investment is expected to further advance the company's products, intended for human use, and solidify its position as a key player in the biotechnology sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $353.00K | - | 06 Jul 2016 | |
| Venture Round | $267.50K | - | 09 Sep 2014 | |
| Venture Round | $125.00K | - | 07 Mar 2012 | |
| Venture Round | $684.00K | - | 05 May 2010 | |
| Debt Financing | $150.00K | 1 |
|
07 Apr 2010 |
No recent news or press coverage available for Celsense.
-Biotechnology-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
